scholarly journals Mouse Models in Meningioma Research: A Systematic Review

Cancers ◽  
2021 ◽  
Vol 13 (15) ◽  
pp. 3712
Author(s):  
Julien Boetto ◽  
Matthieu Peyre ◽  
Michel Kalamarides

Meningiomas are the most frequent primitive central nervous system tumors found in adults. Mouse models of cancer have been instrumental in understanding disease mechanisms and establishing preclinical drug testing. Various mouse models of meningioma have been developed over time, evolving in light of new discoveries in our comprehension of meningioma biology and with improvements in genetic engineering techniques. We reviewed all mouse models of meningioma described in the literature, including xenograft models (orthotopic or heterotopic) with human cell lines or patient derived tumors, and genetically engineered mouse models (GEMMs). Xenograft models provided useful tools for preclinical testing of a huge range of innovative drugs and therapeutic options, which are summarized in this review. GEMMs offer the possibility of mimicking human meningiomas at the histological, anatomical, and genetic level and have been invaluable in enabling tumorigenesis mechanisms, including initiation and progression, to be dissected. Currently, researchers have a range of different mouse models that can be used depending on the scientific question to be answered.

2013 ◽  
Vol 24 ◽  
pp. i7
Author(s):  
I.J. Huijbers ◽  
R. Bin Ali ◽  
C. Pritchard ◽  
M. Cozijnsen ◽  
N. Proost ◽  
...  

Author(s):  
Alexander F Haddad ◽  
Jacob S Young ◽  
Dominic Amara ◽  
Mitchel S Berger ◽  
David R Raleigh ◽  
...  

Abstract Glioblastoma (GBM) is an incurable brain tumor with a median survival of approximately 15 months despite an aggressive standard of care that includes surgery, chemotherapy, and ionizing radiation. Mouse models have advanced our understanding of GBM biology and the development of novel therapeutic strategies for GBM patients. However, model selection is crucial when testing developmental therapeutics, and each mouse model of GBM has unique advantages and disadvantages that can influence the validity and translatability of experimental results. To shed light on this process, we discuss the strengths and limitations of 3 types of mouse GBM models in this review: syngeneic models, genetically engineered mouse models (GEMMs), and xenograft models, including traditional xenograft cell lines and patient-derived xenograft (PDX) models.


Sign in / Sign up

Export Citation Format

Share Document